On Wednesday evening, the 5th U.S. Circuit Court of Appeal granted the Justice Department’s emergency request and partially blocked (TFG appointed) Judge Kacsmaryk’s ludicrous ruling that suspended the Food and Drug Administration’s original approval of mifepristone. But, the Court left restrictions in place that would prevent it from being sent to patients in the mail; patients must make an in-person visit to obtain the drug. It also shortened the window from ten to seven to ten weeks gestation and patients must have three appointments as opposed to one. The patient must also take the pill in the healthcare provider’s establishment versus in the comfort of her own home.
The case is expected to reach the Extreme Court.
